30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Carisma Therapeutics Inc (CARM)

Track

The most recent insider trading activity occurred on October 7, 2025, with Michael Klichinsky, an officer, proposing a sale of shares valued at $14,182.82 and selling shares worth $14,484.82. Prior to this, on October 3rd and 2nd, Klichinsky sold shares totaling $31,077.96 and $50,860.00 respectively. Earlier transactions in March 2023 involved multiple executives selling shares.
Stock chart
Ticker: CARM Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Klichinsky Michael
Chief Scientific Officer
1 sale — total 14,485 USD
Sale 7 Oct 2025
Value US$2,583,542.49 | Price 203.10 | Shares 35,119
Proposed sale 7 Oct 2025
Value US$4,269,504.80 | Price 36.85 | Shares 44,373
Sale 3 Oct 2025
Value US$31,077.96 | Price 0.26 | Shares 119,347
Sale 2 Oct 2025
Value US$50,860.00 | Price 0.25 | Shares 200,000
Sale 1 Oct 2025
Value US$42,405.00 | Price 0.26 | Shares 165,000
Sale 2 Mar 2023
Value US$163,517.07 | Price 0.59 | Shares 278,564
Sale 2 Mar 2023
Value US$122,637.80 | Price 0.59 | Shares 208,923
Sale 2 Mar 2023
Value US$26,343.97 | Price 0.59 | Shares 44,879
Sale 2 Mar 2023
Value US$43,062.91 | Price 0.59 | Shares 73,361
Sale 2 Mar 2023
Value US$59,274.09 | Price 0.59 | Shares 100,978
Sale 2 Mar 2023
Value US$57,704.45 | Price 0.59 | Shares 98,304
Sale 2 Mar 2023
Value US$54,754.77 | Price 0.59 | Shares 93,279
Sale 2 Mar 2023
Value US$90,554.14 | Price 0.59 | Shares 154,266
Sale 2 Mar 2023
Value US$10,148.64 | Price 0.59 | Shares 17,289
Sale 2 Mar 2023
Value US$19,892.26 | Price 0.59 | Shares 33,888
Sale 2 Mar 2023
Value US$35,359.12 | Price 0.59 | Shares 60,237
Sale 2 Mar 2023
Value US$44,756.99 | Price 0.59 | Shares 76,247
Sale 21 Feb 2023
Value US$31,553.87 | Price 0.59 | Shares 53,727
Sale 21 Feb 2023
Value US$15,226.93 | Price 0.59 | Shares 25,927
Sale 21 Feb 2023
Value US$23,392.75 | Price 0.59 | Shares 39,831
Sale 21 Feb 2023
Value US$36,331.55 | Price 0.59 | Shares 61,862
Sale 21 Feb 2023
Value US$4,204.48 | Price 0.59 | Shares 7,159
Sale 14 Feb 2017
Value US$2,937.90 | Price 2.10 | Shares 1,399
Sale 28 Sep 2016
Value US$30,093.00 | Price 3.00 | Shares 10,031
Sale 23 Sep 2016
Value US$31,908.30 | Price 3.10 | Shares 10,293
Sale 23 Sep 2016
Value US$127,651.80 | Price 3.10 | Shares 41,178
Sale 23 Sep 2016
Value US$9,852.88 | Price 3.16 | Shares 3,118
Sale 23 Sep 2016
Value US$39,443.12 | Price 3.16 | Shares 12,482
Sale 22 Sep 2016
Value US$149,275.30 | Price 3.17 | Shares 47,090
Sale 22 Sep 2016
Value US$597,123.39 | Price 3.17 | Shares 188,367
Sale 22 Sep 2016
Value US$89,558.34 | Price 3.18 | Shares 28,163
Sale 22 Sep 2016
Value US$358,484.58 | Price 3.18 | Shares 112,731
Sale 21 Sep 2016
Value US$241,908.75 | Price 3.75 | Shares 64,509
Sale 21 Sep 2016
Value US$968,302.50 | Price 3.75 | Shares 258,214
Sale 20 Sep 2016
Value US$36,537.42 | Price 3.39 | Shares 10,778
Sale 20 Sep 2016
Value US$146,241.21 | Price 3.39 | Shares 43,139
Sale 19 Sep 2016
Value US$6,418.09 | Price 3.31 | Shares 1,939
Sale 19 Sep 2016
Value US$25,688.91 | Price 3.31 | Shares 7,761
Sale 15 Sep 2016
Value US$2,229.76 | Price 4.16 | Shares 536
Sale 15 Sep 2016
Value US$8,923.20 | Price 4.16 | Shares 2,145
Sale 14 Sep 2016
Value US$36,792.36 | Price 4.18 | Shares 8,802
Sale 14 Sep 2016
Value US$147,173.62 | Price 4.18 | Shares 35,209
Sale 7 Sep 2016
Value US$36,733.95 | Price 4.51 | Shares 8,145
Sale 7 Sep 2016
Value US$147,012.47 | Price 4.51 | Shares 32,597
Sale 7 Sep 2016
Value US$238,962.35 | Price 4.51 | Shares 52,985
Sale 6 Sep 2016
Value US$14,390.04 | Price 4.63 | Shares 3,108
Sale 6 Sep 2016
Value US$57,601.83 | Price 4.63 | Shares 12,441
Sale 6 Sep 2016
Value US$93,623.23 | Price 4.63 | Shares 20,221
Sale 15 Aug 2016
Value US$5,616.00 | Price 4.80 | Shares 1,170
Sale 27 Jun 2016
Value US$20,860.32 | Price 2.08 | Shares 10,029
Sale 27 Jun 2016
Value US$9,093.76 | Price 2.08 | Shares 4,372
Sale 13 Jun 2016
Value US$486,089.87 | Price 2.74 | Shares 177,140
Sale 13 Jun 2016
Value US$2,373,262.33 | Price 2.74 | Shares 864,860
Sale 16 Feb 2016
Value US$405.27 | Price 0.27 | Shares 1,501
Sale 8 May 2015
Value US$441,882.00 | Price 13.23 | Shares 33,400
Sale 2 Feb 2015
Value US$207,998.00 | Price 11.62 | Shares 17,900
Sale 30 Jan 2015
Value US$706,200.00 | Price 11.77 | Shares 60,000
Sale 29 Jan 2015
Value US$630,300.00 | Price 11.46 | Shares 55,000
Sale 28 Jan 2015
Value US$57,900.00 | Price 11.58 | Shares 5,000
Sale 27 Jan 2015
Value US$25,652.00 | Price 11.66 | Shares 2,200
Sale 26 Jan 2015
Value US$1,187.00 | Price 11.87 | Shares 100
Sale 26 Jan 2015
Value US$1,182.00 | Price 11.82 | Shares 100
Sale 26 Jan 2015
Value US$70.86 | Price 11.81 | Shares 6
Sale 26 Jan 2015
Value US$5,868.72 | Price 11.88 | Shares 494
Sale 26 Jan 2015
Value US$1,177.00 | Price 11.77 | Shares 100
Sale 26 Jan 2015
Value US$1,168.00 | Price 11.68 | Shares 100
Sale 26 Jan 2015
Value US$2,306.00 | Price 11.53 | Shares 200
Sale 26 Jan 2015
Value US$2,300.00 | Price 11.50 | Shares 200
Sale 23 Jan 2015
Value US$43,601.60 | Price 11.90 | Shares 3,664
Sale 23 Jan 2015
Value US$3,567.00 | Price 11.89 | Shares 300
Sale 23 Jan 2015
Value US$1,188.00 | Price 11.88 | Shares 100
Sale 23 Jan 2015
Value US$6,362.32 | Price 11.87 | Shares 536
Sale 23 Jan 2015
Value US$1,186.00 | Price 11.86 | Shares 100
Sale 23 Jan 2015
Value US$1,176.00 | Price 11.76 | Shares 100
Sale 23 Jan 2015
Value US$1,170.00 | Price 11.70 | Shares 100
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-08 2025-10-07 S Sale
3.7
Klichinsky Michael

Chief Scientific Officer

Officer
35,119 +19.6%
203.10
US$2,583,542 		35,119 +19.6% 203.10 US$2,583,542
2025-10-06 2025-10-07 PrS Proposed sale
3.7
MICHAEL KLICHINSKY

OFFICER

Officer
44,373
36.85
US$4,269,505 		44,373 36.85 US$4,269,505
2025-10-03 2025-10-03 S Sale
3.7
Klichinsky Michael

Chief Scientific Officer

Officer
48,494 -39.2%
486.12
US$3,230,894 		48,494 -39.2% 486.12 US$3,230,894
2025-10-03 2025-10-02 S Sale
3.7
Klichinsky Michael

Chief Scientific Officer

Officer
200,000 -62.6%
0.25
US$50,860 		200,000 -62.6% 0.25 US$50,860
2025-10-03 2025-10-01 S Sale
3.7
Klichinsky Michael

Chief Scientific Officer

Officer
165,000 -34.1%
0.26
US$42,405 		165,000 -34.1% 0.26 US$42,405
2023-03-06 2023-03-02 S Sale
3.6
Cannell Thomas R

President and CEO

Executive Director
278,564 -29.3%
0.59
US$163,517 		278,564 -29.3% 0.59 US$163,517
2023-03-06 2023-03-02 S Sale
3.6
Cannell Thomas R

President and CEO

Executive Director
208,923 -37.8%
0.59
US$122,638 		208,923 -37.8% 0.59 US$122,638
2023-03-06 2023-03-02 S Sale
3.6
Sullivan Mark

General Counsel & Secretary

Officer
44,879 -10.6%
0.59
US$26,344 		44,879 -10.6% 0.59 US$26,344
2023-03-06 2023-03-02 S Sale
3.6
Sullivan Mark

General Counsel & Secretary

Officer
73,361 -19.1%
0.59
US$43,063 		73,361 -19.1% 0.59 US$43,063
2023-03-06 2023-03-02 S Sale
3.6
Sullivan Mark

General Counsel & Secretary

Officer
100,978 -33.7%
0.59
US$59,274 		100,978 -33.7% 0.59 US$59,274
2023-03-06 2023-03-02 S Sale
3.6
Forbes Monica

Chief Financial Officer

Officer
98,304 -16.3%
0.59
US$57,704 		98,304 -16.3% 0.59 US$57,704
2023-03-06 2023-03-02 S Sale
3.6
Forbes Monica

Chief Financial Officer

Officer
93,279 -18.1%
0.59
US$54,755 		93,279 -18.1% 0.59 US$54,755
2023-03-06 2023-03-02 S Sale
3.6
Forbes Monica

Chief Financial Officer

Officer
154,266 -32.1%
0.59
US$90,554 		154,266 -32.1% 0.59 US$90,554
2023-03-06 2023-03-02 S Sale
3.6
Ryu Elly

Principal Accounting Officer

Officer
17,289 -10.4%
0.59
US$10,149 		17,289 -10.4% 0.59 US$10,149
2023-03-06 2023-03-02 S Sale
3.6
MacDonald Glen C

Chief Technology Officer

Officer
33,888 -7.8%
0.59
US$19,892 		33,888 -7.8% 0.59 US$19,892
2023-03-06 2023-03-02 S Sale
3.6
MacDonald Glen C

Chief Technology Officer

Officer
60,237 -15.4%
0.59
US$35,359 		60,237 -15.4% 0.59 US$35,359
2023-03-06 2023-03-02 S Sale
3.6
MacDonald Glen C

Chief Technology Officer

Officer
76,247 -26.9%
0.59
US$44,757 		76,247 -26.9% 0.59 US$44,757
2023-02-23 2023-02-21 S Sale
3.6
Cannell Thomas R

President and CEO

Executive Director
53,727 -8.9%
0.59
US$31,554 		53,727 -8.9% 0.59 US$31,554
2023-02-23 2023-02-21 S Sale
3.6
MacDonald Glen C

Chief Technology Officer

Officer
25,927 -8.4%
0.59
US$15,227 		25,927 -8.4% 0.59 US$15,227
2023-02-23 2023-02-21 S Sale
3.6
Sullivan Mark

General Counsel & Secretary

Officer
39,831 -11.7%
0.59
US$23,393 		39,831 -11.7% 0.59 US$23,393
2023-02-23 2023-02-21 S Sale
3.6
Forbes Monica

Chief Financial Officer

Officer
61,862 -11.4%
0.59
US$36,332 		61,862 -11.4% 0.59 US$36,332
2023-02-23 2023-02-21 S Sale
3.6
Ryu Elly

Principal Accounting Officer

Officer
7,159 -4.1%
0.59
US$4,204 		7,159 -4.1% 0.59 US$4,204
2017-02-16 2017-02-14 S Sale
3.1
MCCABE JOHN J

Chief Financial Officer

Officer
1,399 -19.1%
2.10
US$2,938 		1,399 -19.1% 2.10 US$2,938
2016-09-30 2016-09-28 S Sale
3.3
Celniker Abbie
Non-Executive Director
10,031 -2.4%
3.00
US$30,093 		10,031 -2.4% 3.00 US$30,093
2016-09-26 2016-09-23 S Sale Flagship Ventures Fund IV, L.P. Large shareholder
10,293 -8.8%
3.10
US$31,908 		10,293 -8.8% 3.10 US$31,908
2016-09-26 2016-09-23 S Sale Flagship Ventures Fund IV, L.P. Large shareholder
41,178 -8.8%
3.10
US$127,652 		41,178 -8.8% 3.10 US$127,652
2016-09-26 2016-09-23 S Sale Flagship Ventures Fund IV, L.P. Large shareholder
3,118 -2.6%
3.16
US$9,853 		3,118 -2.6% 3.16 US$9,853
2016-09-26 2016-09-23 S Sale Flagship Ventures Fund IV, L.P. Large shareholder
12,482 -2.6%
3.16
US$39,443 		12,482 -2.6% 3.16 US$39,443
2016-09-26 2016-09-22 S Sale Flagship Ventures Fund IV, L.P. Large shareholder
47,090 -28.1%
3.17
US$149,275 		47,090 -28.1% 3.17 US$149,275
2016-09-26 2016-09-22 S Sale Flagship Ventures Fund IV, L.P. Large shareholder
188,367 -28.2%
3.17
US$597,123 		188,367 -28.2% 3.17 US$597,123
2016-09-26 2016-09-22 S Sale Flagship Ventures Fund IV, L.P. Large shareholder
28,163 -14.4%
3.18
US$89,558 		28,163 -14.4% 3.18 US$89,558
2016-09-26 2016-09-22 S Sale Flagship Ventures Fund IV, L.P. Large shareholder
112,731 -14.4%
3.18
US$358,485 		112,731 -14.4% 3.18 US$358,485
2016-09-21 2016-09-21 S Sale Flagship Ventures Fund IV, L.P. Large shareholder
64,509 -24.8%
3.75
US$241,909 		64,509 -24.8% 3.75 US$241,909
2016-09-21 2016-09-21 S Sale Flagship Ventures Fund IV, L.P. Large shareholder
258,214 -24.8%
3.75
US$968,302 		258,214 -24.8% 3.75 US$968,302
2016-09-21 2016-09-20 S Sale Flagship Ventures Fund IV, L.P. Large shareholder
10,778 -4.0%
3.39
US$36,537 		10,778 -4.0% 3.39 US$36,537
2016-09-21 2016-09-20 S Sale Flagship Ventures Fund IV, L.P. Large shareholder
43,139 -4.0%
3.39
US$146,241 		43,139 -4.0% 3.39 US$146,241
2016-09-21 2016-09-19 S Sale Flagship Ventures Fund IV, L.P. Large shareholder
1,939 -0.7%
3.31
US$6,418 		1,939 -0.7% 3.31 US$6,418
2016-09-21 2016-09-19 S Sale Flagship Ventures Fund IV, L.P. Large shareholder
7,761 -0.7%
3.31
US$25,689 		7,761 -0.7% 3.31 US$25,689
2016-09-16 2016-09-15 S Sale Flagship Ventures Fund IV, L.P. Large shareholder
536 -0.2%
4.16
US$2,230 		536 -0.2% 4.16 US$2,230
2016-09-16 2016-09-15 S Sale Flagship Ventures Fund IV, L.P. Large shareholder
2,145 -0.2%
4.16
US$8,923 		2,145 -0.2% 4.16 US$8,923
2016-09-16 2016-09-14 S Sale Flagship Ventures Fund IV, L.P. Large shareholder
8,802 -3.1%
4.18
US$36,792 		8,802 -3.1% 4.18 US$36,792
2016-09-16 2016-09-14 S Sale Flagship Ventures Fund IV, L.P. Large shareholder
35,209 -3.1%
4.18
US$147,174 		35,209 -3.1% 4.18 US$147,174
2016-09-08 2016-09-07 S Sale Flagship Ventures Fund IV, L.P. Large shareholder
8,145 -2.8%
4.51
US$36,734 		8,145 -2.8% 4.51 US$36,734
2016-09-08 2016-09-07 S Sale Flagship Ventures Fund IV, L.P. Large shareholder
32,597 -2.8%
4.51
US$147,012 		32,597 -2.8% 4.51 US$147,012
2016-09-08 2016-09-07 S Sale Flagship Ventures Fund IV, L.P. Large shareholder
52,985 -2.8%
4.51
US$238,962 		52,985 -2.8% 4.51 US$238,962
2016-09-08 2016-09-06 S Sale Flagship Ventures Fund IV, L.P. Large shareholder
3,108 -1.1%
4.63
US$14,390 		3,108 -1.1% 4.63 US$14,390
2016-09-08 2016-09-06 S Sale Flagship Ventures Fund IV, L.P. Large shareholder
12,441 -1.1%
4.63
US$57,602 		12,441 -1.1% 4.63 US$57,602
2016-09-08 2016-09-06 S Sale Flagship Ventures Fund IV, L.P. Large shareholder
20,221 -1.1%
4.63
US$93,623 		20,221 -1.1% 4.63 US$93,623
2016-08-17 2016-08-15 S Sale MCCABE JOHN J

Chief Financial Officer

Officer
1,170 -13.8%
4.80
US$5,616 		1,170 -13.8% 4.80 US$5,616
2016-06-29 2016-06-27 S Sale Celniker Abbie

President and CEO

Executive Director
10,029 -2.3%
2.08
US$20,860 		10,029 -2.3% 2.08 US$20,860
2016-06-29 2016-06-27 S Sale Tubridy Karen L

Chief Development Officer

Officer
4,372 -11.8%
2.08
US$9,094 		4,372 -11.8% 2.08 US$9,094
2016-06-14 2016-06-13 S Sale Boxer Capital, LLC Large shareholder
177,140 -37.3%
2.74
US$486,090 		177,140 -37.3% 2.74 US$486,090
2016-06-14 2016-06-13 S Sale Boxer Capital, LLC Large shareholder
864,860 -38.3%
2.74
US$2,373,262 		864,860 -38.3% 2.74 US$2,373,262
2016-02-17 2016-02-16 S Sale MCCABE JOHN J

Senior Vice President, Finance

Officer
1,501 -15.0%
0.27
US$405 		1,501 -15.0% 0.27 US$405
2015-05-11 2015-05-08 S Sale JAFCO Super V3 Investment Limited Partnership Large shareholder
33,400 -1.7%
13.23
US$441,882 		33,400 -1.7% 13.23 US$441,882
2015-02-03 2015-02-02 S Sale JAFCO Super V3 Investment Limited Partnership Large shareholder
17,900 -0.9%
11.62
US$207,998 		17,900 -0.9% 11.62 US$207,998
2015-01-30 2015-01-30 S Sale JAFCO Super V3 Investment Limited Partnership Large shareholder
60,000 -2.9%
11.77
US$706,200 		60,000 -2.9% 11.77 US$706,200
2015-01-30 2015-01-29 S Sale JAFCO Super V3 Investment Limited Partnership Large shareholder
55,000 -2.6%
11.46
US$630,300 		55,000 -2.6% 11.46 US$630,300
2015-01-30 2015-01-28 S Sale JAFCO Super V3 Investment Limited Partnership Large shareholder
5,000 -0.2%
11.58
US$57,900 		5,000 -0.2% 11.58 US$57,900
2015-02-09 2015-01-27 S Sale JAFCO Super V3 Investment Limited Partnership Large shareholder
2,200 -0.1%
11.66
US$25,652 		2,200 -0.1% 11.66 US$25,652
2015-01-26 2015-01-26 S Sale JAFCO Super V3 Investment Limited Partnership Large shareholder
100 -0.0%
11.87
US$1,187 		100 -0.0% 11.87 US$1,187
2015-01-26 2015-01-26 S Sale JAFCO Super V3 Investment Limited Partnership Large shareholder
100 -0.0%
11.82
US$1,182 		100 -0.0% 11.82 US$1,182
2015-01-26 2015-01-26 S Sale JAFCO Super V3 Investment Limited Partnership Large shareholder
6 -0.0%
11.81
US$71 		6 -0.0% 11.81 US$71
2015-01-26 2015-01-26 S Sale JAFCO Super V3 Investment Limited Partnership Large shareholder
494 -0.0%
11.88
US$5,869 		494 -0.0% 11.88 US$5,869
2015-01-26 2015-01-26 S Sale JAFCO Super V3 Investment Limited Partnership Large shareholder
100 -0.0%
11.77
US$1,177 		100 -0.0% 11.77 US$1,177
2015-01-26 2015-01-26 S Sale JAFCO Super V3 Investment Limited Partnership Large shareholder
100 -0.0%
11.68
US$1,168 		100 -0.0% 11.68 US$1,168
2015-01-26 2015-01-26 S Sale JAFCO Super V3 Investment Limited Partnership Large shareholder
200 -0.0%
11.53
US$2,306 		200 -0.0% 11.53 US$2,306
2015-01-26 2015-01-26 S Sale JAFCO Super V3 Investment Limited Partnership Large shareholder
200 -0.0%
11.50
US$2,300 		200 -0.0% 11.50 US$2,300
2015-01-26 2015-01-23 S Sale JAFCO Super V3 Investment Limited Partnership Large shareholder
3,664 -0.2%
11.90
US$43,602 		3,664 -0.2% 11.90 US$43,602
2015-01-26 2015-01-23 S Sale JAFCO Super V3 Investment Limited Partnership Large shareholder
300 -0.0%
11.89
US$3,567 		300 -0.0% 11.89 US$3,567
2015-01-26 2015-01-23 S Sale JAFCO Super V3 Investment Limited Partnership Large shareholder
100 -0.0%
11.88
US$1,188 		100 -0.0% 11.88 US$1,188
2015-01-26 2015-01-23 S Sale JAFCO Super V3 Investment Limited Partnership Large shareholder
536 -0.0%
11.87
US$6,362 		536 -0.0% 11.87 US$6,362
2015-01-26 2015-01-23 S Sale JAFCO Super V3 Investment Limited Partnership Large shareholder
100 -0.0%
11.86
US$1,186 		100 -0.0% 11.86 US$1,186
2015-01-26 2015-01-23 S Sale JAFCO Super V3 Investment Limited Partnership Large shareholder
100 -0.0%
11.76
US$1,176 		100 -0.0% 11.76 US$1,176
2015-01-26 2015-01-23 S Sale JAFCO Super V3 Investment Limited Partnership Large shareholder
100 -0.0%
11.70
US$1,170 		100 -0.0% 11.70 US$1,170
Explore more

More insider trading research around Carisma Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America